Bill Sponsor
House Bill 2125
117th Congress(2021-2022)
Quit Because of COVID–19 Act
Introduced
Introduced
Introduced in House on Mar 23, 2021
Overview
Text
Introduced
Mar 23, 2021
Latest Action
Mar 24, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2125
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Colorado
Democrat
Connecticut
Democrat
District of Columbia
Democrat
Illinois
Democrat
Maryland
Democrat
Maryland
Democrat
Massachusetts
Democrat
Massachusetts
Democrat
Massachusetts
Democrat
Minnesota
Democrat
Minnesota
Democrat
Minnesota
Democrat
Mississippi
Democrat
New Hampshire
Democrat
New Hampshire
Democrat
New Jersey
Democrat
New York
Democrat
New York
Democrat
New York
Democrat
North Carolina
Democrat
North Carolina
Republican
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Tennessee
Democrat
Wisconsin
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Quit Because of COVID-19 Act

This bill provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services.

Specifically, the bill provides for coverage, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines. It also applies a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for such items and services during the public health emergency relating to COVID-19 and for two years after the emergency period ends.

Text (1)
March 23, 2021
Actions (3)
03/24/2021
Referred to the Subcommittee on Health.
03/23/2021
Referred to the House Committee on Energy and Commerce.
03/23/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:48:05 PM